Dipeptidyl Peptidase-4 Inhibitors and Risk of Heart Failure in Patients With Type 2 Diabetes Mellitus

Young-Gun Kim,Dukyong Yoon,Soo-Young Park,Seung Jin Han,Dae Jung Kim,Kwan-Woo Lee,Rae Woong Park,Hae-Jin Kim

Dipeptidyl Peptidase-4 Inhibitors and Risk of Heart Failure in Patients With Type 2 Diabetes Mellitus

2017

Young-Gun Kim
Dukyong Yoon
Soo-Young Park
Seung Jin Han
Dae Jung Kim
Kwan-Woo Lee
Rae Woong Park
Hae-Jin Kim

Background:The association between dipeptidyl-peptidase IV inhibitors (DPP-4i) and heart failure (HF) remains unclear. In 1 randomized controlled trial and some observational studies, DPP-4i report...

Keywords:

Dipeptidyl-Peptidase IV Inhibitors
Type 2 Diabetes Mellitus
Heart failure
Randomized controlled trial
Diabetes mellitus
Cardiology
Dipeptidyl peptidase-4
Internal medicine
Observational study
Medicine
Myocardial infarction

Correction
Cite
Save
Machine Reading By IdeaReader

References

Citations